本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atrium Therapeutics

8.21
-0.1900-2.26%
盘后:8.210.00000.00%19:30 EDT
成交量:8.74万
成交额:72.16万
市值:1.40亿
市盈率:-2.13
高:8.48
开:8.40
低:8.21
收:8.40
52周最高:16.77
52周最低:7.63
股本:1,710.56万
流通股本:1,572.10万
量比:0.27
换手率:0.56%
股息:- -
股息率:- -
每股收益(TTM):-3.8578
每股收益(LYR):-3.1905
净资产收益率:-43.98%
总资产收益率:-399.25%
市净率:0.65
市盈率(LYR):-2.57

数据加载中...

2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/03

重要事件披露

Form 8-K - Current report
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities